Press Releases
Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases
"PRM-151 will complement our growing early-stage fibrosis portfolio, and we are excited by its potential to address multiple fibrotic diseases." Bristol-Myers Squibb...
Press Releases
Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute Announce Worldwide Collaboration to Discover Novel Immuno-Oncology Antibodies
"We are excited to work with QIMR Berghofer Medical Research Institute, a partner that brings significant experience and expertise in cancer research." ...
Press Releases
Lilly To Participate In Morgan Stanley Global Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015. Sue Mahony, Ph.D., senior vice president...
Press Releases
U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients...
This acceptance for review marks the first in the U.S. for a SLAMF7-directed immunostimulatory antibody "AbbVie is encouraged by the FDA’s...
Press Releases
U.S. District Court Rules In Lilly’s Favor On Alimta Vitamin Regimen Patent
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor...
Press Releases
Lilly, AACE Mark 10th Anniversary Of Hurricane Katrina With Reminder Of “My Diabetes Emergency Plan” Checklist
The checklist, now in its ninth year, is a direct result of post-Katrina learnings ,For Sherry Martin, M.D., starting her new job at Eli...
Press Releases
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
Twenty-two abstracts to be presented, including new analyses from ARISTOTLE and real-world data analyses evaluating the risk of major bleeding, bleeding-related hospital readmissions, hospitalization rates...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.